Moleculin Biotech (MBRX) Update / Briefing Transcript

Moleculin Biotech (MBRX) Update / Briefing June 05, 2025 08:30 AM ET Speaker0 Hello, and welcome to the Molecular Biotech Key Opinion Leader Webcast to discuss the company's positive top line efficacy results from its MB-one hundred seven U. S. Phase 1btwo clinical trial evaluating an antiomycin for the treatment of soft tissue sarcoma lung metastases. At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations or future proje ...